|
2025
|
Invention
|
Antitumor parasporin-2 derived toxins. The invention relates to a recombinant parasporin 2 protei... |
|
|
Invention
|
Oncolytic adenovirus with controlled replication. The present invention relates to oncolytic viru... |
|
2023
|
Invention
|
Pd-ecgf as biomarker of cancer. The present invention corresponds to the field of cancer and is r... |
|
|
Invention
|
Adenovirus comprising an albumin-binding moiety.
The invention relates to a recombinant adenovir... |
|
2022
|
Invention
|
Patient positioning system for radiation emission treatment and/or diagnosis equipment. The inven... |
|
2021
|
Invention
|
Methods for predicting the risk of local invasion and/or metastasis induced by an antiangiogenic ... |
|
2020
|
Invention
|
Adenovirus comprising an albumin-binding moiety. The invention relates to a recombinant adenoviru... |
|
2017
|
Invention
|
Prognostic biomarker for cancer. The invention relates to an in vitro method for determining the ... |
|
2016
|
Invention
|
Compounds for the treatment of cancer and/or cancer treatment resistance by inhibition of cancer ... |
|
|
Invention
|
Methods and compositions for the treatment of anti-angiogenic resistant cancer. The present inven... |
